These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27020777)
41. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707 [TBL] [Abstract][Full Text] [Related]
42. Bioluminescence based in vivo screening technologies. Kelkar M; De A Curr Opin Pharmacol; 2012 Oct; 12(5):592-600. PubMed ID: 22954534 [TBL] [Abstract][Full Text] [Related]
43. Membrane structure and interactions of peptide hormones with model lipid bilayers. Sikorska E; IĆowska E; Wyrzykowski D; Kwiatkowska A Biochim Biophys Acta; 2012 Dec; 1818(12):2982-93. PubMed ID: 22824299 [TBL] [Abstract][Full Text] [Related]
44. Split Gaussia luciferase-based bioluminescence template for tracing protein dynamics in living cells. Kim SB; Sato M; Tao H Anal Chem; 2009 Jan; 81(1):67-74. PubMed ID: 19061336 [TBL] [Abstract][Full Text] [Related]
45. Fluorescence and bioluminescence procedures for functional proteomics. Prinz A; Reither G; Diskar M; Schultz C Proteomics; 2008 Mar; 8(6):1179-96. PubMed ID: 18283669 [TBL] [Abstract][Full Text] [Related]
46. Utilizing a Simple Method for Stoichiometric Protein Labeling to Quantify Antibody Blockade. Friedman Ohana R; Hurst R; Rosenblatt M; Levin S; Machleidt T; Kirkland TA; Encell LP; Robers MB; Wood KV Sci Rep; 2019 May; 9(1):7046. PubMed ID: 31065015 [TBL] [Abstract][Full Text] [Related]
50. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Pfleger KD; Seeber RM; Eidne KA Nat Protoc; 2006; 1(1):337-45. PubMed ID: 17406254 [TBL] [Abstract][Full Text] [Related]
52. A bioluminescent assay for the sensitive detection of proteases. Leippe DM; Nguyen D; Zhou M; Good T; Kirkland TA; Scurria M; Bernad L; Ugo T; Vidugiriene J; Cali JJ; Klaubert DH; O'Brien MA Biotechniques; 2011 Aug; 51(2):105-10. PubMed ID: 21806554 [TBL] [Abstract][Full Text] [Related]
53. Rapid methods of detecting the target molecule in immunohistology using a bioluminescence probe. Wu C; Wang KY; Guo X; Sato M; Ozaki M; Shimajiri S; Ohmiya Y; Sasaguri Y Luminescence; 2013; 28(1):38-43. PubMed ID: 22407540 [TBL] [Abstract][Full Text] [Related]
57. Cage the firefly luciferin! - a strategy for developing bioluminescent probes. Li J; Chen L; Du L; Li M Chem Soc Rev; 2013 Jan; 42(2):662-76. PubMed ID: 23099531 [TBL] [Abstract][Full Text] [Related]
58. Exploring the binding site crevice of a family B G protein-coupled receptor, the type 1 corticotropin releasing factor receptor. Gkountelias K; Papadokostaki M; Javitch JA; Liapakis G Mol Pharmacol; 2010 Oct; 78(4):785-93. PubMed ID: 20664003 [TBL] [Abstract][Full Text] [Related]
59. Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis. Schaub FX; Reza MS; Flaveny CA; Li W; Musicant AM; Hoxha S; Guo M; Cleveland JL; Amelio AL Cancer Res; 2015 Dec; 75(23):5023-33. PubMed ID: 26424696 [TBL] [Abstract][Full Text] [Related]